Suspected Economically Motivated Adulteration of FDA-Regulated Products Cosmetics and Personal Care Products John E. Bailey Executive Vice President -

Slides:



Advertisements
Similar presentations
Biopharmaceutical Quality
Advertisements

Food Science: An Old but New Subject History of Food Science
Office of New Animal Drug Evaluation Laura L. Hungerford, DVM, MPH, PhD Senior Advisor, Science and Policy, ONADE Professor, University of Maryland School.
Producing a Pharmaceutical or Biopharmaceutical
HACCP.
Consumer Safety and Drug Regulations
George J. Soleas, Ph.D. SVP-Logistics/Quality Assurance QA Program at the LCBO: Why test? Who benefits?
Marketing malpractice It involves misleading descriptions and high – pressure sales techniques and may also include an increasing number of sales via internet.
POULTRY BRINE INJECTION DAFF AND DTI PRESENTATION Dr. NTSHABELE DIRECTOR: FOOD SAFETY AND QUALITY ASSURANCE PORTFOLIO COMMITTEE ON AGRICULTURE, FORESTRY.
FEDERAL REGULATIONS OF MEDICATIONS Food, Drug and Cosmetic Act Protect consumers from adulterated and misbranded foods, drugs, cosmetics, or devices.
Quality control of raw materials In-process control
Tony Gould Quality Risk Management. 2 | PQ Workshop, Abu Dhabi | October 2010 Introduction Risk management is not new – we do it informally all the time.
Reference, Retention and Reserve Samples
Field Investigators: ADE Detectives. Section One Introduction to the Team and Their Roles.
1. RCC Industry Panel – Consumer Products Presentation to RCC Stakeholder Dialogue Session June 20, 2013 Darren Praznik President & CEO, Canadian Cosmetic,
Huzairy Hassan School of Bioprocess Engineering UniMAP.
© 2009 Michigan State University licensed under CC-BY-SA, original at Corrective Action.
Probiotics: Safety Issues Francis B Palumbo, PhD, Esq. University of Maryland School of Pharmacy Center on Drugs & Public Policy.
International Health and Safety at Work
THE IMPORTANCE OF THE FOOD SCIENCE INDUSTRY Agriscience 102 Applied Agricultural Science and Technology #8408 TEKS: (c)(5)(A)
Current Good Manufacturing Practices (cGMP’s). Biotechnology using living cells and materials produced by cells to create pharmaceutical, diagnostic,
Ashland Specialty Ingredients IFAC’s cGMP Audit Guide How the Food Ingredient Industry has Responded to FSMA and Food Safety Audits Priscilla Zawislak.
Prepared by: Taruna Navraksha Irfaan Shashi Food Quality & Certification.
Module 5Slide 1 of 24 WHO - EDM Part One, Sections 6 and 7 Basic Principles of GMP Complaints and Recalls.
Project co-financed by European Union Project co- financed by Asean European Committee for Standardization Implementing Agency 1 Module 13 GMP Workshop.
Annette Krawczyk-Sheets Professor Anne-Marie Yerks English Composition 106 Online 15 December 2010.
Food quality means general features and criteria by means of which food is characterized considering its nutritional value, organoleptic quality and safety.
Good Manufacturing Practice. Good Manufacturing Practice Regulations Establishes minimum GMP for methods to be used, and the facilities or controls to.
© 2009 Michigan State University licensed under CC-BY-SA, original at Product Contamination Control.
What does it mean? What is it used for? S. Greubel.
Chapter 17 Food Safety. Copyright 2010, John Wiley & Sons, Inc. Food Safety Talk Foodborne illness: any illness that is related to the consumption of.
BASIC PRINCIPLES IN OCCUPATIONAL HYGIENE Day ASSESSMENT OF HEALTH RISKS.
Implementation of the Proposed Canada Consumer Product Safety Act (Bill C-6) Mandatory Reporting Health Canada ICPHSO 2009, Toronto.
Proposed Regulations for Foreign Supplier Verification Programs (FSVPs)
FAO/WHO Codex Training Package Module 2.8 FAO/WHO CODEX TRAINING PACKAGE SECTION TWO – UNDERSTANDING THE ORGANIZATION OF CODEX 2.8 Is there a format for.
Preventive Controls for Human Food S upplemental Proposal 1
Foreign Supplier Verification Programs Supplemental Proposal 1.
CALIFORNIA proposed SAFER CONSUMER PRODUCT REGULATIONS Marjorie MartzEmerson October 24, 2012.
Proposed Rule for Preventive Controls for Animal Food.
Proposed Rule: 21 CFR 507 Proposed Rule for Preventive Controls for Animal Food 1.
Reclaimed Wastewater Quality Criteria, Standards, and Guidelines
By Michelle Hoang Period 2 APES April 30, 2012 The Toxic Substances Control Act of 1976.
Final Rule for Preventive Controls for Animal Food 1 THE FUTURE IS NOW.
TTMA Workshop September 30 th What Is HACCP? H - Hazard A - Analysis C - Critical C - Control P - Point HACCP is a food safety management system.
Pharmaceutical post operational activities
Basic Principles of GMP
The Regulation of Cosmetics PHT 435. FDCA Definition Articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied.
Producing a Pharmaceutical or Biopharmaceutical The Manufacturing Process.
Good Manufacturing Practice (GMP) Compliance: GMPs EXPLAINED.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
Storage, Labeling, Controlled Medications Guidance Training CFR § (b)(2)(3)(d)(e) F431.
Role of Public Quality Standards Ben A. Firschein, J.D., LL.M. Director, U.S. Government Affairs Panel on Nutritional Supplements Conference of Western.
KEVIN BEDAL LISA CARLIN MATT CARROLL ERIN NICHOLS Product Safety & Failure Analysis.
Warm-Up In your journal, write a minimum, 5 sentence paragraph that describes what you just watched in the video.
Carryover and Functional Use Maia M. Jack, Ph.D. Vice President, Science and Regulatory Affairs.
The target: Regulated industries
Executive Director, Registrar Corp
Producing a Pharmaceutical or Biopharmaceutical
Food Production Systems
Quality Risk Management
Introduction to GMP.
Competition in Markets
Producing a Pharmaceutical or Biopharmaceutical
H A C C P HAZARD ANALYSIS CRITICAL CONTROL POINTS 1 December 2018
Marketing malpractice
Producing a Pharmaceutical or Biopharmaceutical
Producing a Pharmaceutical or Biopharmaceutical
Final Rule on Foreign Supplier Verification Programs
The British Retail Consortium (BRC)
A FRIENDLY REMINDER ON OTC DRUGS. DRUG REGULATIONS IN THE PHILIPPINES.
Presentation transcript:

Suspected Economically Motivated Adulteration of FDA-Regulated Products Cosmetics and Personal Care Products John E. Bailey Executive Vice President - Science Personal Care Products Council 1

Economically Motivated Adulteration of FDA-Regulated Products FDA proposes a working definition of EMA as the fraudulent, intentional substitution or addition of a substance in a product for the purpose of increasing the apparent value of the product or reducing the cost of its production, i.e., for economic gain. 2

Economically Motivated Adulteration of FDA- Regulated Products EMA includes dilution of products with increased quantities of an already-present substance (e.g., increasing inactive ingredients of a drug with a resulting reduction in strength of the finished product, or watering down of juice) to the extent that such dilution poses a known or possible health risk to consumers, as well as the addition or substitution of substances in order to mask dilution. 3

Economically Motivated Adulteration of FDA- Regulated Products Economically Motivated Adulteration may arise from the following sources: – Dilution of an ingredient to reduce the costs of manufacturing. – Substitution of one ingredient for another cheaper ingredient without changing the ingredient declaration on the product label. – Intentional omission of an ingredient that is otherwise included in the ingredient declaration on the product label.

Economically Motivated Adulteration of FDA- Regulated Products Cosmetic products that are sold at retail for use by consumers are required to bear a full declaration of ingredients used in the formulation of the product. Cosmetics present only a minimal risk of causing harm to the consumer. Most products are applied topically and do not penetrate the skin. 5

Economically Motivated Adulteration of FDA- Regulated Products Some products, such as lipsticks, mouth washes, breath fresheners and toothpastes, are subject to incidental oral exposure. A very limited number of products are actually introduced into the body (i.e., vaginal douches for personal hygiene cleansing purposes is classified as a cosmetic). 6

Economically Motivated Adulteration of FDA- Regulated Products Economically Motivated Adulteration may potentially have an adverse health impact if: – The user is allergic to an ingredient that is not declared on the label (a very rare event and of low probability). – The omission or substitution of an ingredient causes the preservative system to fail and the product becomes contaminated with harmful microorganisms. 7

Economically Motivated Adulteration of FDA- Regulated Products Identified instances of EMA in the area of cosmetics are extremely rare and have not resulted in any known harm to human health. Most EMA has been associated with counterfeit products. Individual companies and product retailers take steps to reduce the occurrence of EMA and counterfeit products. 8

Economically Motivated Adulteration of FDA- Regulated Products The Personal Care Products Council has taken a number of steps to help companies set up systems that will minimize the opportunity for EMA to occur: – Worked within ISO TC-217 to develop international Good Manufacturing Practices standard (ISO International Standard 22716). – Developed and published a Quality Assurance and GMP Guideline that helps ensure proper control of raw materials and manufacturing/packaging. 9

Economically Motivated Adulteration of FDA- Regulated Products The Personal Care Products Council has taken a number of steps to help companies set up systems that will minimize the opportunity for EMA to occur: – Developed and distributed a Raw Material Information Form as a tool to promote uniformity in identification and characterization for ingredients. – Published a Product Security Guideline for the cosmetics industry. – Worked with FDA and Customs on how to control and spot counterfeit products. 10

The Personal Care Products Council believes the following indicators might be used to detect potential EMA: Products that are marketed outside of established retail channels or outlets (i.e. marketing on the internet outside of the established retail channels). Failure of ingredients to meet established identity and chemical specifications. Economically Motivated Adulteration of FDA- Regulated Products 11

Economically Motivated Adulteration of FDA- Regulated Products Products that do not bear valid lot codes. Product performance. Product appearance. Packaging appearance or defects. 12